Zobrazeno 1 - 10
of 572
pro vyhledávání: '"Dennis, Barnes"'
Machimus lecythus (Walker), new combination (Fig. 51) The following description is based on one male and two female pupal cases of M. lecythus with associated pinned adults from the United States National Museum. All three specimens are labeled "Agaw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c94edcb1cf8e1fce1305d1ef5f51c782
Autor:
Harshal Deshmukh, Kazeem A. Adeleke, Emmanuel Ssemmondo, Emma G. Wilmot, Najeeb Shah, Beatrice Pieri, Robert Gregory, Anne Kilvert, Alistair Lumb, Peter Christian, Dennis Barnes, Jane Patmore, Chris Walton, Robert E. J. Ryder, Thozhukat Sathyapalan
Publikováno v:
Diabetic Medicine.
Autor:
Thomas S J, Crabtree, Karen, Adamson, Hazel, Reid, Dennis, Barnes, Siva, Sivappriyan, Alex, Bickerton, Ian W, Gallen, Benjamin C T, Field, Iskandar, Idris, Robert E J, Ryder
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1398-1401
The ABCD semaglutide audit was designed to capture the routine clinical outcomes of people commenced on semaglutide in the UK. Previous work showed differential reductions in HbA1c and weight dependent on previous glucagon-like peptide-1 receptor ago
Autor:
Harshal Deshmukh, Emma Wilmot, Beatrice Pieri, Pratik Choudhary, Najeeb Shah, Robert Gregory, Anne Kilvert, Alistair Lumb, Peter Christian, Dennis Barnes, Jane Patmore, Chris Walton, Robert E. J. Ryder, Thozhukat Sathyapalan
Publikováno v:
Diabetic Medicine. 39
The aim of this study was to understand the relationship between time in range (TIR) achieved using the isCGM with changes in glycaemic control, diabetes-related distress (DRD) and resource utilisation in people living with diabetes.Clinicians from 1
Autor:
Beatrice Pieri, Harshal Deshmukh, Emma G. Wilmot, Pratik Choudhary, Najeeb Shah, Robert Gregory, Dennis Barnes, Simon Saunders, Jane Patmore, Chris Walton, Robert E. J. Ryder, Thozhukat Sathyapalan
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 25(1)
Autor:
Roselle Herring, Anne Kilvert, Robert E.J. Ryder, Dennis Barnes, Shafie Kamaruddin, Robert Gregory, Rumaisa Banatwalla, Emma G. Wilmot, Simon Saunders, Parth Narendran, Jane Patmore, Thozhukat Sathyapalan, C.D. Walton, Niall Furlong, Harshal Deshmukh
Publikováno v:
Diabetes, Obesity and Metabolism. 23:2261-2268
AIM To identify the baseline demographic and clinical characteristics associated with diabetes-related distress (DRD) and factors associated with improvement in DRD after initiating use of the FreeStyle Libre (FSL) in people living with type 1 diabet
Autor:
Dennis Barnes, Anurita Rohilla, Alex Bickerton, Robert Ej Ryder, Rajeev Raghavan, Abcd Empagliflozin Audit Contributors, Suzanne Phillips, Devesh Sennik, Ian W. Gallen, Alison Evans, Siva Sivappriyan, Jackie Elliott, Thomas Sj Crabtree
Publikováno v:
British Journal of Diabetes. 21:62-66
Introduction: Evidence from phase III and the EMPA-REG OUTCOME trials have demonstrated improvements in renal endpoints with empagliflozin use. The EMPA-KIDNEY trial is currently underway and is assessing whether there are benefits of empagliflozin i
Autor:
THOMAS S.J. CRABTREE, DEVESH K. SENNIK, ALEX BICKERTON, DENNIS BARNES, SIVA SIVAPPRIYAN, KAREN ADAMSON, SUZANNE M. PHILLIPS, ALISON EVANS, NIELS LARSEN, AVINASH PANESAR, MELISSA L. CULL, IAN W. GALLEN, ISKANDAR R. IDRIS, ROBERT E. RYDER
Publikováno v:
Diabetes. 71
Obesity and type 2 diabetes are important drivers for the development of nonalcoholic fatty liver disease (NAFLD) . Glucagon-like peptide-1 receptor agonists (GLP1RAs) are efficacious for these conditions, but their potential as treatments for NAFLD
Autor:
null Beatrice Pieri, null Harshal Deshmukh, null Emma G. Wilmot, null Pratik Choudhary, null Najeeb Shah, null Robert Gregory, null Dennis Barnes, null Simon Saunders, null Jane Patmore, null Chris Walton, null Robert E.J Ryder, null Thozhukat Sathyapalan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3253154de33ddb1c1ef7c5cce845ab4
https://doi.org/10.1111/dom.14841/v2/response1
https://doi.org/10.1111/dom.14841/v2/response1
Autor:
Anne Kilvert, Jane Patmore, C.D. Walton, Rumaisa Banatwalla, Robert Gregory, Shafie Kamaruddin, Dennis Barnes, Harshal Deshmukh, Thozhukat Sathyapalan, Emma G. Wilmot, Niall Furlong, Roselle Herring, Robert E.J. Ryder, Simon Saunders, Parth Narendran
Publikováno v:
Diabetes Care
OBJECTIVE The FreeStyle Libre (FSL) flash glucose-monitoring device was made available on the U.K. National Health Service (NHS) drug tariff in 2017. This study aims to explore the U.K. real-world experience of FSL and the impact on glycemic control,